| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |